Postpartum Isn’t a Niche. It’s Infrastructure

What allocators get wrong about women’s health, and where the next returns will come from

The “impact” label sounds good but for women’s health start-ups, it can quietly cap capital, compress returns, and stall scale. Here is what investors and allocators need to rethink.